Aarvik Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2M

  • Investors
  • 1

Aarvik Therapeutics General Information

Description

Operator of a proprietary modular platform intended to develop site-specific antibody-drug conjugation technology. The company tool is being used to generate a pipeline of proprietary multi-functional ADCs that engage multiple epitopes/targets to result in effective treatments where previous-generation ADCs failed or were sub-optimal and develop novel molecules with an improved therapeutic index for oncology targets, enabling biotechnology companies to create transformational benefits for cancer patients.

Contact Information

Formerly Known As
Aarkus Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 31363 Medallion Drive
  • Hayward, CA 94544
  • United States
+1 (408)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 31363 Medallion Drive
  • Hayward, CA 94544
  • United States
+1 (408)

Aarvik Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aarvik Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 29-Sep-2025 $2M Completed Generating Revenue
2. Early Stage VC (Series A) 10-Dec-2024 Completed Generating Revenue
1. Seed Round 02-Sep-2021 $8.32M $8.32M Completed Generating Revenue
To view Aarvik Therapeutics’s complete valuation and funding history, request access »

Aarvik Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Aarvik Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aarvik Therapeutics Patents

Aarvik Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026232141-A1 B7h3/trop2 antibodies and methods of use Pending 02-May-2025
WO-2026183370-A2 B7h3/epha2 antibodies and methods of use Pending 27-Feb-2025
WO-2026183370-A3 B7h3/epha2 antibodies and methods of use Pending 27-Feb-2025
US-20260256939-A1 Fluorocamptothecin compounds, conjugates, and methods thereof Pending 07-May-2024
WO-2025235686-A1 Fluorocamptothecin compounds, conjugates, and methods thereof Pending 07-May-2024 A61K47/68037
To view Aarvik Therapeutics’s complete patent history, request access »

Aarvik Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aarvik Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Laurus Labs Corporation Minority
To view Aarvik Therapeutics’s complete investors history, request access »

Aarvik Therapeutics FAQs

  • When was Aarvik Therapeutics founded?

    Aarvik Therapeutics was founded in 2020.

  • Where is Aarvik Therapeutics headquartered?

    Aarvik Therapeutics is headquartered in Hayward, CA.

  • What is the size of Aarvik Therapeutics?

    Aarvik Therapeutics has 11 total employees.

  • What industry is Aarvik Therapeutics in?

    Aarvik Therapeutics’s primary industry is Drug Discovery.

  • Is Aarvik Therapeutics a private or public company?

    Aarvik Therapeutics is a Private company.

  • What is Aarvik Therapeutics’s current revenue?

    The current revenue for Aarvik Therapeutics is .

  • How much funding has Aarvik Therapeutics raised over time?

    Aarvik Therapeutics has raised $11.5M.

  • Who are Aarvik Therapeutics’s investors?

    Laurus Labs has invested in Aarvik Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process